Mineralogy affects geoavailability, bioaccessibility and bioavailability of zinc.

R. Molina,L. Schaider,Thomas C. Donaghey,J. Shine,J. Brain

DOI: https://doi.org/10.1016/j.envpol.2013.07.013

IF: 8.9

2013-11-01

Environmental Pollution

Abstract:

What problem does this paper attempt to address?

Skewed X-chromosome inactivation drives the proportion of DNAAF6 -defective airway motile cilia and variable expressivity in primary ciliary dyskinesia

Lucie Thomas,Laurence Cuisset,Jean-Francois Papon,Aline Tamalet,Isabelle Pin,Rola Abou Taam,Catherine Faucon,Guy Montantin,Sylvie Tissier,Philippe Duquesnoy,Florence Dastot - Le Moal,Bruno Copin,Nathalie Carion,Bruno Louis,Sandra Chantot-Bastaraud,Jean-Pierre Siffroi,Rana Mitri,André Coste,Estelle Escudier,Guillaume Thouvenin,Serge Amselem,Marie Legendre

DOI: https://doi.org/10.1136/jmg-2023-109700

2024-02-26

Journal of Medical Genetics

Abstract:Background Primary ciliary dyskinesia (PCD) is a rare airway disorder caused by defective motile cilia. Only male patients have been reported with pathogenic mutations in X-linked DNAAF6 , which result in the absence of ciliary dynein arms, whereas their heterozygous mothers are supposedly healthy. Our objective was to assess the possible clinical and ciliary consequences of X-chromosome inactivation (XCI) in these mothers. Methods XCI patterns of six mothers of male patients with DNAAF6 -related PCD were determined by DNA-methylation studies and compared with their clinical phenotype (6/6 mothers), as well as their ciliary phenotype (4/6 mothers), as assessed by immunofluorescence and high-speed videomicroscopy analyses. The mutated X chromosome was tracked to assess the percentage of cells with a normal inactivated DNAAF6 allele. Results The mothers’ phenotypes ranged from absence of symptoms to mild/moderate or severe airway phenotypes, closely reflecting their XCI pattern. Analyses of the symptomatic mothers’ airway ciliated cells revealed the coexistence of normal cells and cells with immotile cilia lacking dynein arms, whose ratio closely mirrored their XCI pattern. Conclusion This study highlights the importance of searching for heterozygous pathogenic DNAAF6 mutations in all female relatives of male PCD patients with a DNAAF6 defect, as well as in females consulting for mild chronic respiratory symptoms. Our results also demonstrate that about one-third—ranging from 20% to 50%—normal ciliated airway cells sufficed to avoid severe PCD, a result paving the way for gene therapy.

genetics & heredity
Evaluation of Advanced Artificial Neural Network Classification and Feature Extraction Techniques for Detecting Preterm Births Using EHG Records

P. Fergus,I. Idowu,A. Hussain,Chelsea Dobbins,H. Alaskar

DOI: https://doi.org/10.1007/978-3-319-09330-7_37

2014-08-03

Abstract:
Transcriptional analysis of primary ciliary dyskinesia airway cells reveals a dedicated cilia glutathione pathway

Jeffrey R Koenitzer,Deepesh Kumar Gupta,Wang Kyaw Twan,Huihui Xu,Nicholas Hadas,Finn J Hawkins,Mary Lou Beermann,Gervette M Penny,Nathan T Wamsley,Andrew Berical,Michael B Major,Susan K Dutcher,Steven L Brody,Amjad Horani

DOI: https://doi.org/10.1172/jci.insight.180198

IF: 9.4958

2024-07-23

JCI Insight

Abstract:Primary ciliary dyskinesia (PCD) is a genetic condition that results in dysmotile cilia. The repercussions of cilia dysmotility and gene variants on the multiciliated cell remain poorly understood. We used single-cell RNA-Seq, proteomics, and advanced microscopy to compare primary culture epithelial cells from patients with PCD, their heterozygous mothers, and healthy individuals, and we induced pluripotent stem cells (iPScs) generated from a patient with PCD. Transcriptomic analysis revealed unique signatures in PCD airway cells compared with their mothers' cells and the cells of healthy individuals. Gene expression in heterozygous mothers' cells diverged from both control and PCD cells, marked by increased inflammatory and cellular stress signatures. Primary and iPS-derived PCD multiciliated cells had increased expression of glutathione-S-transferases GSTA2 and GSTA1, as well as NRF2 target genes, accompanied by elevated levels of reactive oxygen species (ROS). Immunogold labeling in human cilia and proteomic analysis of the ciliated organism Chlamydomonas reinhardtii demonstrated that GSTA2 localizes to motile cilia. Loss of human GSTA2 and C. reinhardtii GSTA resulted in slowed cilia motility, pointing to local cilia regulatory roles. Our findings identify cellular responses unique to PCD variants and independent of environmental stress and uncover a dedicated ciliary GSTA2 pathway essential for normal motility that may be a therapeutic target.
Chronic airway disease in primary ciliary dyskinesia-spiced with geno-phenotype associations

Kim G Nielsen,Mathias G Holgersen,Suzanne Crowley,June K Marthin

DOI: https://doi.org/10.1002/ajmg.c.31967

Abstract:Primary ciliary dyskinesia (PCD) can be defined as a multiorgan ciliopathy with a dominant element of chronic airway disease affecting the nose, sinuses, middle ear, and in particular, the lower airways. Although most patients with PCD are diagnosed during preschool years, it is obvious that the chronic lung disease starts its course already from birth. The many faces of the clinical picture change, as does lung function, structural lung damage, the burden of infection, and of treatment throughout life. A markedly severe neutrophil inflammation in the respiratory tract seems pervasive and is only to a minimal extent ameliorated by a treatment strategy, which is predominantly aimed at bacterial infections. An ever-increasing understanding of the different aspects, their interrelationships, and possible different age courses conditioned by the underlying genotype is the focus of much attention. The future is likely to offer personalized medicine in the form of mRNA therapy, but to that end, it is of utmost importance that all patients with PCD be carefully characterized and given a genetic diagnosis. In this narrative review, we have concentrated on lower airways and summarized the current understanding of the chronic airway disease in this motile ciliopathy. In addition, we highlight the challenges, gaps, and opportunities in PCD lung disease research.
Topological data analysis reveals genotype–phenotype relationships in primary ciliary dyskinesia

Amelia Shoemark,Bruna Rubbo,Marie Legendre,Mahmoud R. Fassad,Eric G. Haarman,Sunayna Best,Irma C.M. Bon,Joost Brandsma,Pierre-Regis Burgel,Gunnar Carlsson,Siobhan B. Carr,Mary Carroll,Matt Edwards,Estelle Escudier,Isabelle Honoré,David Hunt,Gregory Jouvion,Michel R. Loebinger,Bernard Maitre,Deborah Morris-Rosendahl,Jean-Francois Papon,Camille M. Parsons,Mitali P. Patel,N. Simon Thomas,Guillaume Thouvenin,Woolf T. Walker,Robert Wilson,Claire Hogg,Hannah M. Mitchison,Jane S. Lucas

DOI: https://doi.org/10.1183/13993003.02359-2020

IF: 24.3

2021-01-21

European Respiratory Journal

Abstract:Background Primary ciliary dyskinesia (PCD) is a heterogeneous inherited disorder caused by mutations in approximately 50 cilia-related genes. PCD genotype–phenotype relationships have mostly arisen from small case series because existing statistical approaches to investigating relationships have been unsuitable for rare diseases. Methods We applied a topological data analysis (TDA) approach to investigate genotype–phenotype relationships in PCD. Data from separate training and validation cohorts included 396 genetically defined individuals carrying pathogenic variants in PCD genes. To develop the TDA models, 12 clinical and diagnostic variables were included. TDA-driven hypotheses were subsequently tested using traditional statistics. Results Disease severity at diagnosis, measured by forced expiratory volume in 1 s (FEV 1 ) z-score, was significantly worse in individuals with CCDC39 mutations (compared to other gene mutations) and better in those with DNAH11 mutations; the latter also reported less neonatal respiratory distress. Patients without neonatal respiratory distress had better preserved FEV 1 at diagnosis. Individuals with DNAH5 mutations were phenotypically diverse. Cilia ultrastructure and beat pattern defects correlated closely to specific causative gene groups, confirming these tests can be used to support a genetic diagnosis. Conclusions This large scale, multi-national study presents PCD as a syndrome with overlapping symptoms and variations in phenotype according to genotype. TDA modelling confirmed genotype–phenotype relationships reported by smaller studies ( e.g. FEV 1 worse with CCDC39 mutation) and identified new relationships, including FEV 1 preservation with DNAH11 mutations and diversity of severity with DNAH5 mutations.

respiratory system
Understanding primary ciliary dyskinesia

Thomas Ferkol

DOI: https://doi.org/10.1002/ppul.27360

IF: 4.0899

2024-10-30

Pediatric Pulmonology

Abstract:Primary ciliary dyskinesia (PCD) is a rare, inherited disease characterized by impaired motile ciliary function leading to chronic sinopulmonary disease, persistent middle ear effusions, laterality defects, and subfertility. Over fifty PCD‐associated genes have also been identified, which have provided new insights into the processes involved into ciliary assembly, structure, and function. Historically, the diagnosis of PCD was based on the presence of ultrastructural defects in the ciliary axoneme but with identification of a growing number of disease‐associated genes, genetic testing has become a first‐line diagnostic tool. Other approaches have also evolved, that have improved our diagnostic capabilities. Treatments for PCD have lagged, and though our growing understanding of the genetic and pathophysiological bases of the disease of PCD may yield to better therapeutic strategies.

pediatrics,respiratory system
Airway ciliary microenvironment responses in mice with primary ciliary dyskinesia and central pair apparatus defects

Casey W. McKenzie,Reesa M. Wilcox,Oduduabasi J. Isaiah,Michael S. Kareta,Lance Lee

DOI: https://doi.org/10.1038/s41598-024-79877-z

IF: 4.6

2024-11-24

Scientific Reports

Abstract:Dysfunction of motile cilia can impair mucociliary clearance in the airway and result in primary ciliary dyskinesia (PCD). We previously showed that mutations in central pair apparatus (CPA) genes perturb ciliary motility and result in PCD in mouse models. However, little is known about how epithelial cell types in the ciliary microenvironment of the upper airway respond to defects in ciliary motility and mucociliary clearance. Here, we have used single-cell RNA sequencing to investigate responses in tracheal epithelial cells from mice with mutations in CPA genes Cfap221/ Pcdp1 , Cfap54 , and Spef2 . Expected cell types were identified, along with an unidentified cell type not expressing markers of typical airway cells. Deuterosomal cells were found to exist in two states that differ largely in expression of genes involved in differentiation into ciliated cells. Functional enrichment analysis of differentially expressed genes (DEGs) revealed important cellular functions and molecular pathways for each cell type that are altered in mutant mice. Overlapping DEGs shed light on general responses to cilia dysfunction, while unique DEGs indicate that some responses may be specific to the individual mutation and ciliary defect.

multidisciplinary sciences
Case report 569

R. Sanchez,S. Quinn,A. Walling,J. Estrada,V. White

DOI: https://doi.org/10.1007/BF00368623

Skeletal Radiology

Abstract:
Characterization of the Human Ciliary Motor Assembly Protein Complex in Primary Ciliary Dyskinesia

R. M. Fewell,A. B. Budan Caliskan,I. Santaliz,S. P. Gunsten,T. Huang,A. Ustione,D. J. Foust,D. W. Piston,A. Horani,S. L. Brody

DOI: https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3388

IF: 24.7

2021-01-01

American Journal of Respiratory and Critical Care Medicine

Abstract:Rationale: Motile cilia are essential for airway clearance and when genetically impaired result in chronic airway infections that characterize the disease primary ciliary dyskinesia (PCD).Given the complex structure of motile cilia, it is not surprising that mutations in nearly 50 proteins result in PCD.Assembly proteins are a class of proteins found in the cytoplasm that when mutant result in absent ciliary axonemal dynein motors.Based on studies in single cell and non-mammalian model organisms, a group of about 12 proteins called dynein axonemal assembly factors (DNAAFs) are thought to interact within discrete foci in the cytoplasm.The DNAAFs are proposed to orchestrate the construction of dynein motor complexes prior to transport to the cilia.Little is known about where and how this process occurs, and less is known about the process in human airway cells.Methods: Immunofluorescent microscopy was used to localize complexes of assembly proteins in normal human lung tissue.Protein-protein interaction and stoichiometry were determined by fluorescence fluctuation spectroscopy (FFS) of fluorescently-tagged assembly proteins expressed in HEK293T cells.Results: Immunolocalization of a group of assembly proteins known to be mutant in PCD (DNAAF2, DNAAF5, SPAG1) were expressed primarily in ciliated airway cells.Cells showed similar patterns of cytoplasmic distribution, featuring a single perinuclear punctum in some cells, with smaller puncta distributed throughout the cytoplasm.This pattern is different from the appearance in model organisms such as Xenopus which feature several puncta within the cytoplasm.Co-chaperone protein RUVBL1, required for common cellular protein handling, showed an expression pattern similar to the DNAAFs.Client dynein protein DNAI1 was identified only within the perinuclear puncta during airway cell differentiation, and had a lower cytoplasmic signal in mature cells.FFS showed that the three DNAAFs examined exist in large multimers, consistent with a scaffold-like function for dynein motor protein assembly.Expression of human PCD mutant DNAAF2, DNAAF5, and SPAG1 in HEK293 cells resulted in large cytoplasmic collections, which extended uniquely from a perinuclear punctum.Conclusions: These observations suggest DNAAFs colocalize in perinuclear puncta in large multimers.Their location differs in human airway cells from that described in model systems.The localization of the mutant proteins responsible for PCD provides fundamental information in understanding normal and mutant dynein protein assembly for the cilia function.Mutant protein localization establishes key information for testing currently conceived therapeutic strategies, such as complementation of the mutant protein with a normal one.
Development and Initial Characterization of Pigs with DNAI1 Mutations and Primary Ciliary Dyskinesia

Mahmoud H Abou Alaiwa,Brie M Hilkin,Margaret P Price,Nicholas D Gansemer,Michael R Rector,Mal R. Stroik,Linda S Powers,Kristin M Whitworth,Melissa S Samuel,Akansha Jain,Lynda S Ostedgaard,Sarah E Ernst,Winter Philibert,Linda D Boyken,Thomas O Moninger,Philip H Karp,Douglas B Hornick,Patrick L Sinn,Anthony John Fischer,Alejandro A Pezzulo,Paul B McCray,David K Meyerholz,Joseph Zabner,Randall S Prather,Michael J Welsh,David A. Stoltz

DOI: https://doi.org/10.1101/2024.05.22.594822

2024-08-21

Abstract:Mutations in more than 50 different genes cause primary ciliary dyskinesia (PCD) by disrupting the activity of motile cilia that facilitate mucociliary transport (MCT). Knowledge of PCD has come from studies identifying disease-causing mutations, characterizing structural cilia abnormalities, finding genotype-phenotype relationships, and studying the cell biology of cilia. Despite these important findings, we still lack effective treatments and people with PCD have significant pulmonary impairment. As with many other diseases, a better understanding of pathogenic mechanisms may lead to effective treatments. To pursue disease mechanisms, we used CRISPR-Cas9 to develop a PCD pig with a disrupted DNAI1 gene. PCD pig airway cilia lacked the outer dynein arm and had impaired beating. MCT was impaired under both baseline conditions and after cholinergic stimulation in PCD pigs. Neonatal PCD pigs developed neonatal respiratory distress with evidence of atelectasis, air trapping, and airway mucus obstruction. Despite airway mucus accumulation, lung bacterial counts were similar between neonatal wild-type and PCD pigs. Sinonasal disease was present in all neonatal PCD pigs. Older PCD pigs developed worsening airway mucus obstruction, inflammation, and bacterial infection. This pig model closely mimics the disease phenotype seen in people with PCD and can be used to better understand the pathophysiology of PCD airway disease.

Physiology
Ciliary Ultrastructure Assessed by Transmission Electron Microscopy in Adults with Bronchiectasis and Suspected Primary Ciliary Dyskinesia but Inconclusive Genotype

Ben O Staar,Jan Hegermann,Bernd Auber,Raphael Ewen,Sandra von Hardenberg,Ruth Olmer,Isabell Pink,Jessica Rademacher,Martin Wetzke,Felix C Ringshausen

DOI: https://doi.org/10.3390/cells12222651

IF: 6

2023-11-18

Cells

Abstract:Whole-exome sequencing has expedited the diagnostic work-up of primary ciliary dyskinesia (PCD), when used in addition to clinical phenotype and nasal nitric oxide. However, it reveals variants of uncertain significance (VUS) in established PCD genes or (likely) pathogenic variants in genes of uncertain significance in approximately 30% of tested individuals. We aimed to assess genotype-phenotype correlations in adults with bronchiectasis, clinical suspicion of PCD, and inconclusive whole-exome sequencing results using transmission electron microscopy (TEM) and ciliary image averaging by the PCD Detect software. We recruited 16 patients with VUS in CCDC39, CCDC40, CCDC103, DNAH5, DNAH5/CCDC40, DNAH8/HYDIN, DNAH11, and DNAI1 as well as variants in the PCD candidate genes DNAH1, DNAH7, NEK10, and NME5. We found normal ciliary ultrastructure in eight patients with VUS in CCDC39, DNAH1, DNAH7, DNAH8/HYDIN, DNAH11, and DNAI1. In six patients with VUS in CCDC40, CCDC103, DNAH5, and DNAI1, we identified a corresponding ultrastructural hallmark defect. In one patient with homozygous variant in NME5, we detected a central complex defect supporting clinical relevance. Using TEM as a targeted approach, we established important genotype-phenotype correlations and definite PCD in a considerable proportion of patients. Overall, the PCD Detect software proved feasible in support of TEM.
Novel Dynein Axonemal Assembly Factor 1 Mutations Identified Using Whole‑exome Sequencing in Patients with Primary Ciliary Dyskinesia

Lei Zhou,Zhuozhe Li,Chunling Du,Cuicui Chen,Yingxin Sun,Liang Gu,Feng Zhou,Yuanlin Song

DOI: https://doi.org/10.3892/mmr.2020.11562

IF: 3.423

2020-01-01

Molecular Medicine Reports

Abstract:Primary ciliary dyskinesia (PCD) is a rare, genetically heterogeneous disorder caused by dysfunction of the cilia and flagella; however, causative genetic defects have not been detected in all patients with PCD. Seven Chinese Han patients with Kartagener syndrome were enrolled onto the present study. Transmission electron microscopy (TEM) was performed to evaluate the cilial defects and whole-exome sequencing was used to analyze relevant genetic variations in all patients. In two of the seven patients with PCD, four novel dynein axonemal assembly factor 1 (DNAAF1) mutations were identified (NM_178452.6:c.3G>A, c.124+1G>C, c.509delG and c.943A>T) in three alleles. Both of these patients had long-standing infertility. Their chest computed tomography results showed bronchiectasis, lung infections and situs inversus, and paranasal computed tomography revealed sinusitis. Semen analysis of the male patient showed poor sperm motility. TEM showed defects in the inner and outer dynein arms in both patients. The DNAAF1 sequences of family members were then analyzed. Bioinformatics analysis indicated that these mutations may be the cause of the cilial defects in these two probands. Thus, the present study identified novel PCD-causing mutations in DNAAF1 in two patients with PCD. These genetic variations were predicted to alter DNAAF1 amino acid residues and lead to loss of function, thereby inhibiting cilia-mediated motility. Accordingly, the two probands had PCD symptoms, and one of them died due to PCD-associated complications.
[The Clinical Characteristics of 17 Cases of Primary Ciliary Dyskinesia].

X L Tian,S B Wang,S Y Zheng,X Li,K F Xu

DOI: https://doi.org/10.3760/cma.j.issn.1001-0939.2017.04.007

2017-01-01

Abstract:Objective: To review the clinical data of cases of primary ciliary dyskinesia (PCD), and to explore the clinical characteristics for the understanding of PCD. Methods: We retrospectively summarized 17 patients with PCD diagnosed in Peking Union Medical College Hospital from Jan 2009 to Dec 2014. There were 7 male and 10 female patients, with the age from 6 to 57 years at the time of diagnosis. The mean onset age of the disease was 11.7±2.1 years, and the mean age at diagnosis was 29.5±3.5 years. We analyzed their clinical symtoms, radiologic images, pulmonary function test and the electron microscopic findings for the clinical characteristics of PCD. Results: The most common onset symptoms were cough (15/17) or sputum (13/17) among our 17 patients with PCD. Only 5 patients had situs inversus in our group. Sixteen patients had bronchiectasis on chest CT scan. Nasal sinusitis was confirmed by nasal CT scan in 15 patients. The most common pathogens from sputum cultures included Pseudomonas aeruginosa, Haemophilus influenzea, Aspergillus fumigates and Candida (3/14 respectively). None of the patients had evidence of mycobacterial infection. Twelve patients underwent spirometry and obstructive pattern was the most common disorder (8/12). Diffusion impairment (5/10) and restrictive pattern dysfunction (3/10) were also present in our patients. Two patients had normal pulmonary function test results. Thirteen patients underwent bronchial mucosal ciliary electron microscopy and the most abnormalities were outer or inner dynein arms deficiency (8/13), and other abnormalities included microtubule arrangement disorder (3/13), reduction of the number of microtubules (3/13) and reduction of the number of dynein arms (2/13). Four of our patients had multiple dysfunctions on their ciliaries. Conclusions: PCD should be considered in bronchiectasis patients with disease onset at childhood even without situs inverse, especially those accompanied with nasal sinusitis or otitis media. Chest or paranasal sinus CT scan, and male sperm examination were helpful for the diagnosis. Mucosal ciliary electron microscopy was an efficient diagnostic method for PCD.
Primary Ciliary Dyskinesia: A Clinical Review

Katherine A. Despotes,Maimoona A. Zariwala,Stephanie D. Davis,Thomas W. Ferkol

DOI: https://doi.org/10.3390/cells13110974

IF: 6

2024-06-04

Cells

Abstract:Primary ciliary dyskinesia (PCD) is a rare, genetically heterogeneous, motile ciliopathy, characterized by neonatal respiratory distress, recurrent upper and lower respiratory tract infections, subfertility, and laterality defects. Diagnosis relies on a combination of tests for confirmation, including nasal nitric oxide (nNO) measurements, high-speed videomicroscopy analysis (HSVMA), immunofluorescent staining, axonemal ultrastructure analysis via transmission electron microscopy (TEM), and genetic testing. Notably, there is no single gold standard confirmatory or exclusionary test. Currently, 54 causative genes involved in cilia assembly, structure, and function have been linked to PCD; this rare disease has a spectrum of clinical manifestations and emerging genotype–phenotype relationships. In this review, we provide an overview of the structure and function of motile cilia, the emerging genetics and pathophysiology of this rare disease, as well as clinical features associated with motile ciliopathies, novel diagnostic tools, and updates on genotype–phenotype relationships in PCD.

cell biology
Considerable variability in the clinical and ciliary features of primary ciliary dyskinesia in patients with DNAH5 mutations

Zhuoyao Guo,Weicheng Chen,Mengru Li,Libo Wang,Liling Qian

DOI: https://doi.org/10.21203/rs.3.rs-1283519/v1

2022-01-01

Abstract:Abstract Background: Primary ciliary dyskinesia (PCD) is a clinically and genetically heterogeneous disorder, but the relationship between genotype and phenotype is poorly established. We aimed to characterize the detailed clinical characteristics, ciliary phenotype and mutational spectrum of PCD patients with DNAH5 mutations.Methods: Whole exome sequencing followed by targeted copy number variation (CNV) analysis was used to screen 114 Chinese patients with highly suspected PCD. In cases with DNAH5 mutation, detailed demographic and clinical data, as well as ciliary beat pattern and ciliary ultrastructure, were comprehensively reviewed. Results: Thirty patients (median, 15.3 years; range, 0.6 to 43 years), who carried DNAH5 mutation, were identified. We characterized 38 novel and 7 known DNAH5 mutations (10 nonsense, 5 frameshift, 10 splicing, 16 missense mutations, 2 in-frame deletions and 2 large deletions). Despite bearing the same genotype, patients presented a highly variable phenotypic picture, including milder respiratory symptom, normal nasal nitric oxide levels (2/21, 9.5%) and “nontypical” ciliary beat pattern (4/21, 19.0%). Conclusions: DNAH5-associated PCD disease demonstrates dramatic phenotypic heterogeneity, contributing to the challenges of diagnosis. A composite work-up and cautious interpretation of the results are necessary during the PCD diagnosis process.
(2)H- and (13)C-labelled tracers compared for kinetic studies of ascorbic acid metabolism in man: a factor analytical approach.

L. Bluck,K. Jones,C. Bates

DOI: https://doi.org/10.1002/RCM.653

IF: 2.586

2002-05-15

Rapid Communications in Mass Spectrometry

Abstract:A recent report that a (13)C stable isotope method can be used to measure the kinetics of ascorbic acid uptake and distribution in man has raised some interesting questions with regard to the physiological interpretation of the data obtained, in particular the sizes of the ascorbate distribution spaces. In order to prove that this result is not a function of the label used we have compared the behaviour of two different tracers to see if they are likely to give comparable results for the kinetic parameters. Volunteers received an oral dose of ascorbic acid, half of which was labelled with (2)H, and half of which was labelled with (13)C. Blood samples were taken over the course of the next 48 h, and ascorbic acid mass spectra measured by gas chromatography/mass spectrometry (GC/MS). Principal component analysis was used to investigate the number of factors required to explain the total variations observed in the ratios of the molecular isotopomer cluster over the time course of the experiment. Theoretical cracking patterns were then used as test vectors in target transformation and as the basis for subsequent combination to determine tracer/tracee ratios. Two factors were found sufficient to account for the observed cracking pattern variations within experimental error. These were identified as (1) the spectrum of unlabelled (endogenous) ascorbic acid, and (2) a linear combination of the spectra of the two labelled species used. The absence of a third factor in the decomposition indicates that there is no difference in the behaviour of the (13)C- and (2)H-labelled tracers. Target testing allowed the tracer/tracee ratios to be determined using calculated cracking patterns, and produced equivalent results to conventional methods. Our experience in this work indicates that factor analysis has a useful place in many kinetic studies of this kind, either with one or many labelled species.
Estimates of primary ciliary dyskinesia prevalence: a scoping review

Wallace B Wee,Dvir Gatt,Elias Seidl,Giles Santyr,Teresa To,Sharon D Dell

DOI: https://doi.org/10.1183/23120541.00989-2023

2024-08-05

Abstract:Background: Primary ciliary dyskinesia (PCD) is a rare multisystem genetic disease caused by dysfunctional motile cilia. Despite PCD being the second most common inherited airway disease after cystic fibrosis, PCD continues to be under-recognised globally owing to nonspecific clinical features and the lack of a gold standard diagnostic test. Commonly repeated prevalence estimates range from one in 10 000 to one in 20 000, based on regional epidemiological studies with known limitations. The purpose of this scoping review was to appraise the PCD literature, to determine the best available global PCD prevalence estimate and to inform the reader about the potential unmet health service needs in PCD. The primary objective of the present study was to systematically review the literature about PCD prevalence estimates. Methods: A scoping review was conducted following the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for scoping reviews (PRISMA-ScR) methodology. Included studies estimated PCD prevalence and used cohort, clinical or genomic data. Case reports, conference abstracts, review articles, animal studies or non-English articles were excluded. Results: A literature review identified 3484 unique abstracts; 34 underwent full-text review and eight met the inclusion/exclusion criteria. Seven articles were based on epidemiological studies of specific geographical regions and provided prevalence estimates that ranged from approximately one to 44.1 in 100 000. Only one study estimated global prevalence, using two large genomic databases, and calculated it to be ∼13.2 in 100 000 (based on pathogenic variants in 29 disease-causing genes). Conclusions: A population-based genomic approach for estimating global prevalence has found that PCD is much more prevalent than previously cited in the literature. This highlights the potential unmet health service needs of people living with PCD.
Case Report: Primary ciliary dyskinesia due to CCNO mutations: a Chinese pediatric case series and literature review

Lejun Tong,Li Li,Wenjian Wang,Jiehua Chen

DOI: https://doi.org/10.3389/fped.2024.1458660

2024-09-24

Abstract:Primary ciliary dyskinesia (PCD) is a hereditary disorder characterized by defects in cilia that impair mucociliary clearance. This study focuses on PCD caused by mutations in the Cyclin O (CCNO) gene and reports on three cases involving Chinese children. Case 1 was an 8-year-and-3-month-old boy who presented with respiratory distress after birth and later developed a recurrent productive cough and purulent nasal discharge. He was initially diagnosed with diffuse panbronchiolitis (DPB) due to the presence of diffuse micronodules in lung CT scans. Case 2 was the younger sister of case 1. She also presented with respiratory distress after birth, with a chest radiograph revealing atelectasis. She required oxygen supplementation until the age of 2 months. Case 3 was a 4-year-and-4-month-old girl with a history of neonatal pneumonia, persistent pulmonary atelectasis, and recurrent lower respiratory tract infections. Her chest radiograph also showed diffuse micronodules. In all three cases, the final diagnosis of PCD was confirmed by genetic testing. Cases 1 and 2 exhibited homozygous c.248_252dup TGCCC (p.G85Cfs*11) mutations in the CCNO gene, while case 3 harbored a homozygous c.258_262dup GGCCC (p.Q88Rfs*8) mutation. A literature review indicated that the common clinical features of CCNO-PCD include neonatal respiratory distress (40/49, 81.6%), chronic cough (31/33, 93.9%), rhinosinusitis (30/35, 85.7%), bronchiectasis (26/35, 74.3%), and low nasal nitric oxide (nNO, 40/43, 93.0%). Notably, situs inversus has not been reported. In CCNO-PCD patients, cilia may appear structurally normal but were severely reduced in number or entirely absent. Lung CT scans in these patients may exhibit diffuse micronodules and "tree-in-bud" signs, which can lead to a clinical misdiagnosis of DPB. nNO screening combined with genetic testing is an optimized diagnostic strategy. Treatment options include the use of anti-infective and anti-inflammatory agent, along with daily airway clearance. This study underscores the importance of genetic testing in neonates and children with suspected PCD or those clinically diagnosed with DPB to enable an early diagnosis and prompt intervention, thereby enhancing the prognosis for these patients.
Combined cellular and gene therapy to treat primary ciliary dyskinesia

C. Bourdais,A. Nasri,F. Foisset,I. Vachier,A. Bourdin,S. Assou,J. De Vos

DOI: https://doi.org/10.1016/j.rmr.2024.01.007

IF: 0.714

2024-03-21

Revue des Maladies Respiratoires

Abstract:Introduction Primary ciliary dyskinesia (PCD) is a genetic disease caused by mutations that alter cilia beating, including in the respiratory airways, resulting in impaired mucus clearance and severe morbidity as well as increased mortality. We hypothesized that we could restore bronchial cilia beating with genetically corrected iPSC differentiated into bronchial progenitors. Methods Our project aims to assess the ability of a corrected iPSC line to functionally repair pathological models in vitro. We generated a PCD patient iPSC line reprogrammed using Sendai viruses, and the corresponding CRISPR/Cas9 corrected cell line, as well a wild-type iPSC line and its CRISPR/Cas9 mutated counterpart. We also generated a GFP-iPSC line expressing the fluorescent GFP protein under the human elongation factor 1 alpha promoter (EF1a), allowing us to study the engraftment ability of GFP bronchial stem cells on a control epithelium model. To assess the efficiency of different bronchial progenitors to engraft a bronchial epithelium, we used our previously published air–liquid interface bronchial epithelium model (iALI). Results One main issue is to identify the competent cell type for regeneration of the adult bronchial epithelium. Indeed, there are several cell types constituting the bronchial epithelium, as well as several developmentally bronchial progenitor cells that could be considered. Our iALI differentiation process mimics the embryonic development and thus the iALI model may provide any cell type from the definitive endoderm to the mature bronchial epithelium. Our results suggest that lung progenitors at the ventralized anterior foregut endoderm stage, could be the most efficient cells for engraftment. Besides, their self-renewal ability and their capacity to differentiate into the different cell type spectrum of the bronchial epithelium are promising for the development of a long-term and efficient therapy. The second issue for bronchial epithelium cell replacement would be to determine the best strategy to erode the bronchi prior to cell therapy. Such an erosion is considered necessary to promote cell engraftment because of the barrier function of the intact bronchial epithelium and the lack of selection advantage from the corrected cells. To this end, we compared mechanical, chemical and enzymatic erosion strategies on the iALI model. Our results suggest a better efficiency with enzymatic erosion, showing a homogeneous detachment of the cells and a better engraftment of cells from the GFP-iPSC line. Conclusion In conclusion, engraftment of corrected lung progenitors to enzymatically eroded bronchial epithelium seems to be a promising therapeutic strategy to treat PCD. Future experiments will refine the best condition regarding enzymatic solution (concentration, time exposure) and graft cell number to assure functional recovery of the mucociliary clearance.

respiratory system
Airport Noise Regulation, Airline Service Quality, and Social Welfare

J. Brueckner,Raquel Girvin

DOI: https://doi.org/10.1016/J.TRB.2007.05.005

2006-10-01

Abstract:

Mineralogy affects geoavailability, bioaccessibility and bioavailability of zinc.

Skewed X-chromosome inactivation drives the proportion of DNAAF6 -defective airway motile cilia and variable expressivity in primary ciliary dyskinesia

Evaluation of Advanced Artificial Neural Network Classification and Feature Extraction Techniques for Detecting Preterm Births Using EHG Records

Transcriptional analysis of primary ciliary dyskinesia airway cells reveals a dedicated cilia glutathione pathway

Chronic airway disease in primary ciliary dyskinesia-spiced with geno-phenotype associations

Topological data analysis reveals genotype–phenotype relationships in primary ciliary dyskinesia

Understanding primary ciliary dyskinesia

Airway ciliary microenvironment responses in mice with primary ciliary dyskinesia and central pair apparatus defects

Case report 569

Characterization of the Human Ciliary Motor Assembly Protein Complex in Primary Ciliary Dyskinesia

Development and Initial Characterization of Pigs with DNAI1 Mutations and Primary Ciliary Dyskinesia

Ciliary Ultrastructure Assessed by Transmission Electron Microscopy in Adults with Bronchiectasis and Suspected Primary Ciliary Dyskinesia but Inconclusive Genotype

Novel Dynein Axonemal Assembly Factor 1 Mutations Identified Using Whole‑exome Sequencing in Patients with Primary Ciliary Dyskinesia

[The Clinical Characteristics of 17 Cases of Primary Ciliary Dyskinesia].

Primary Ciliary Dyskinesia: A Clinical Review

Considerable variability in the clinical and ciliary features of primary ciliary dyskinesia in patients with DNAH5 mutations

(2)H- and (13)C-labelled tracers compared for kinetic studies of ascorbic acid metabolism in man: a factor analytical approach.

Estimates of primary ciliary dyskinesia prevalence: a scoping review

Case Report: Primary ciliary dyskinesia due to CCNO mutations: a Chinese pediatric case series and literature review

Combined cellular and gene therapy to treat primary ciliary dyskinesia

Airport Noise Regulation, Airline Service Quality, and Social Welfare